Find scientific articles, popular press articles, congress participations, and video interviews here.
March 2016: Noor Eye Clinic, Teheran. Our Light for Sight reference site in Teheran brings hope to a young Down Syndrome patient with keratoconus from Tajikistan, through the medium of LfS headquarters in Switzerland . Read the article here.
Schweizer Illustrierte. Keratoconus treatment by cross-linking in children and adolescents, at the ELZA Institute. Read here (article in german).
Noor Eye Clinic, Teheran, Iran. Many thanks to our Reference Site in Teheran, Iran, for treating this 30 year-old Down Syndrome patient from Tajikistan as part of the humanitarian initiative of Light for Sight.
ELZA Institute, Dietikon Zurich, Switzerland. Mannie Ng is the reigning DSISO World Record Holder for the 100 m Back Stroke (1:38.05). She broke the previous world record on December 2, 2008. Ms. Ng is also a gold medal winner in
Ocular Surgery News. Light for Sight unites clinical institutions, research groups, patient organizations and private persons in the mission to combat preventable severe visual impairment caused by keratoconus in children and adolescents. A major component is “Light for Sight 21”,
European Society for Cataract and Refractive Surgery, annual meeting Barcelona 2015. The ELZA member Prof. Farhad Hafezi speaks about best practice models when performing cross-linking in children and adolescents with progressive keratoconus.
CXL for progressive keratoconus in a 12-year-old boy from San Francisco that came to ELZA for treatment. The topography shows a remarkable result early after CXL of the right eye : the cornea did not only stabilize, but shows a flattening
World Down Syndrome Day 2015, Greece. Ophthalmica.gr holds a press conference on the opening of the LfS21 Reference Center in Thessaloniki.
Prof. Hafezi gives an interview on pediatric cross-linking in children and adolescents, at the World Ophthalmology Congress in Tokyo in April 2014.
Ophthalmology Times. Children and adolescents with keratoconus may have rapid progression between the ages of 8 and 19 years and immediate treatment with corneal crosslinking may stop that progression. “When CXL initially began to be used, we always determined that
Sheraz Daya on a humanitarian mission in Tanzania. The corneal cross-linking device was provided by the Light for Sight foundation. Read his article here.
Want to stay informed about our latest news, posts and articles?
© 2023 | Light for Sight Foundation | All rights reserved
